Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis

The effectiveness of disease-modifying drugs in the treatment of multiple sclerosis is associated with adherence. RebiSmart(®) electronic device provides useful information about adherence to the treatment with subcutaneous (sc) interferon (IFN) β-1a (Rebif(®)). The aim of the study was to determine...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Fernández, O., Arroyo, R., Martínez-Yélamos, S., Marco, M., Merino, J. A. García, Muñoz, D., Merino, E., Roque, A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2016
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4985132/
https://ncbi.nlm.nih.gov/pubmed/27526201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0160313
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi